We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Robert Maitta, MD, PhD
Not Accepting New Patients

Robert Maitta, MD, PhD

  • Specialty: Pathology-Clinical
    View Expertise
  • Languages Spoken: English, Spanish

Schedule an Appointment:

Biography: Robert Maitta, MD, PhD

Expertise

  • Alpha-Synuclein
  • Hematopoiesis
  • Immature Platelet Fraction
  • Infectious Diseases
  • Lymphopoiesis
  • Platelet Longevity
  • Sickle Cell Disease
  • Test Development
  • Transfusion Reactions

Titles

  • Assistant Medical Director, Transfusion Medicine and Blood Bank, UH Cleveland Medical Center
  • Medical Director, Apheresis/ FACT/ Stem Cell Collection Center, UH Cleveland Medical Center
  • Associate Professor, CWRU School of Medicine

Certifications & Memberships

  • Blood Banking and Transfusion Medicine - American Board of Pathology
  • Clinical Pathology - American Board of Pathology

Education

Fellowship | Transfusion Medicine
Transfusion Medicine - Yale-New Haven Hospital (2010 - 2011)

Residency | Anatomic and Clinical Pathology
Anatomic and Clinical Pathology - Montefiore Medical Center (2007 - 2010)

Medical Education
Albert Einstein College Of Medicine Of Yeshiva University (2007)

Other Education
Albert Einstein College Of Medicine Of Yeshiva University (2005)

Other Education
Albert Einstein College Of Medicine Of Yeshiva University (2001)

Other Education
The City College Of New York (1996)

Undergraduate
The City College Of New York (1992)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Robert Maitta did not disclose any Outside Relationships with Industry.